Skip to content

CHAMPIONS ONCOLOGY, INC.

CSBR

CIK 0000771856

← back to feed
Revenue (TTM)
$62.63M
+13.5% YoY Q3 Mar 2026
Net Income (TTM)
$4.05M
+164.6% YoY Q3 Mar 2026
EPS Diluted (TTM)
$0.28
+161.1% YoY Q3 Mar 2026
Gross Margin
51.0%
Q3 Mar 2026
Operating Margin
6.2%
Q3 Mar 2026
Net Margin
6.5%
Q3 Mar 2026
Free Cash Flow (TTM)
−$4.74M
Q3 Mar 2026
Cash
$7.13M
Q3 Mar 2026
Total Debt
—
Q3 Mar 2026
Shares Outstanding
13.89M sh
Q3 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings